Literature DB >> 20800172

Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study.

Babak Baseri1, James J Choi, Yao-Sheng Tung, Elisa E Konofagou.   

Abstract

As a potentially viable method of brain drug delivery, the safety profile of blood-brain barrier (BBB) opening using focused ultrasound (FUS) and ultrasound contrast agents (UCA) needs to be established. In this study, we provide a short-term (30-min or 5-h survival) histological assessment of murine brains undergoing FUS-induced BBB opening. Forty-nine mice were intravenously injected with Definity microbubbles (0.05 microL/kg) and sonicated under the following parameters: frequency of 1.525 MHz, pulse length of 20 ms, pulse repetition frequency of 10 Hz, peak rarefactional acoustic pressures of 0.15-0.98 MPa and two 30-s sonication intervals with an intermittent 30-s delay. The BBB opening threshold was found to be 0.15-0.3 MPa based on fluorescence and magnetic resonance imaging of systemically injected tracers. Analysis of three histological measures in hematoxylin and eosin-stained sections revealed the safest acoustic pressure to be within the range of 0.3-0.46 MPa in all examined time periods post sonication. Across different pressure amplitudes, only the samples 30 min post opening showed significant difference (p < 0.05) in the average number of distinct damaged sites, microvacuolated sites, dark neurons and sites with extravasated erythrocytes. Enhanced fluorescence around severed microvessels was also noted and found to be associated with the largest tissue effects, whereas mildly diffuse BBB opening with uniform fluorescence in the parenchyma was associated with no or mild tissue injury. Region-specific areas of the sonicated brain (thalamus, hippocampal fissure, dentate gyrus and CA3 area of hippocampus) exhibited variation in fluorescence intensity based on the position, orientation and size of affected vessels. The results of this short-term histological analysis demonstrated the feasibility of a safe FUS-UCA-induced BBB opening under a specific set of sonication parameters and provided new insights on the mechanism of BBB opening.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800172      PMCID: PMC3968780          DOI: 10.1016/j.ultrasmedbio.2010.06.005

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  45 in total

1.  Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.

Authors:  Kullervo Hynynen; Nathan McDannold; Natalia Vykhodtseva; Scott Raymond; Ralph Weissleder; Ferenc A Jolesz; Nickolai Sheikov
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

3.  Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat.

Authors:  Y Li; C Powers; N Jiang; M Chopp
Journal:  J Neurol Sci       Date:  1998-04-01       Impact factor: 3.181

4.  Is the solitary dark neuron a manifestation of postmortem trauma to the brain inadequately fixed by perfusion?

Authors:  J Cammermeyer
Journal:  Histochemistry       Date:  1978-06-09

5.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

7.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

Authors:  Manabu Kinoshita; Nathan McDannold; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

8.  Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption.

Authors:  Feng-Yi Yang; Wen-Mei Fu; Rong-Sen Yang; Houng-Chi Liou; Kai-Hsiang Kang; Win-Li Lin
Journal:  Ultrasound Med Biol       Date:  2007-06-11       Impact factor: 2.998

9.  Focal destruction of nervous tissue by focused ultrasound: biophysical factors influencing its application.

Authors:  H T BALLANTINE; T F HUETER; W J NAUTA; D M SOSA
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

Review 10.  Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.

Authors:  Michael Weaver; Douglas W Laske
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

View more
  67 in total

1.  Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.

Authors:  Babak Baseri; James J Choi; Thomas Deffieux; Gesthimani Samiotaki; Yao-Sheng Tung; Oluyemi Olumolade; Scott A Small; Barclay Morrison; Elisa E Konofagou
Journal:  Phys Med Biol       Date:  2012-03-09       Impact factor: 3.609

Review 2.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

Review 3.  Therapeutic strategies to improve drug delivery across the blood-brain barrier.

Authors:  Tej D Azad; James Pan; Ian D Connolly; Austin Remington; Christy M Wilson; Gerald A Grant
Journal:  Neurosurg Focus       Date:  2015-03       Impact factor: 4.047

4.  In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice.

Authors:  Yao-Sheng Tung; Fotios Vlachos; James J Choi; Thomas Deffieux; Kirsten Selert; Elisa E Konofagou
Journal:  Phys Med Biol       Date:  2010-09-29       Impact factor: 3.609

Review 5.  Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.

Authors:  Dallan McMahon; Charissa Poon; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2019-01-29       Impact factor: 6.648

6.  Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo.

Authors:  James J Choi; Jameel A Feshitan; Babak Baseri; Shougang Wang; Yao-Sheng Tung; Mark A Borden; Elisa E Konofagou
Journal:  IEEE Trans Biomed Eng       Date:  2009-10-20       Impact factor: 4.538

7.  Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles.

Authors:  James J Choi; Kirsten Selert; Fotios Vlachos; Anna Wong; Elisa E Konofagou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

8.  Effects of the microbubble shell physicochemical properties on ultrasound-mediated drug delivery to the brain.

Authors:  Shih-Ying Wu; Cherry C Chen; Yao-Sheng Tung; Oluyemi O Olumolade; Elisa E Konofagou
Journal:  J Control Release       Date:  2015-06-09       Impact factor: 9.776

Review 9.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

10.  Safety Validation of Repeated Blood-Brain Barrier Disruption Using Focused Ultrasound.

Authors:  Thiele Kobus; Natalia Vykhodtseva; Magdalini Pilatou; Yongzhi Zhang; Nathan McDannold
Journal:  Ultrasound Med Biol       Date:  2015-11-23       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.